Features | Partner Sites | Information | LinkXpress
Sign In
AMPRONIX
SCHILLER AG
TERARECON, INC.

Real-Time Planning for Ultrasound-Guided Brachytherapy with Data Analysis Tool Designed to Reduce Clutter

By Medimaging International staff writers
Posted on 04 Dec 2013
To support real-time planning for ultrasound-guided brachytherapy, a new application’s modular design reports the angular and linear position intraoperatively direct to the manufacturer’s treatment planning software. Through direct communication, the new device offers rapid connection for data analysis and reduces disorder in the surgical suite.

Civco Medical Solutions (Coralville, IA, USA) furthers real-time planning capabilities with US Food and Drug Administration (FDA) 510(k) clearance of the EX3 Stepper for low dose rate (LDR) and high dose rate (HDR) ultrasound-guided brachytherapy for prostate cancer detection and treatment. The unique design of the stepper also features a removable electronic unit, which mitigates the risk of damaging transmission components and reduces cleaning time after the procedure.

LDR prostate brachytherapy involves internal radiotherapy where tiny radioactive “seeds” are delivered through a needle and are permanently placed into or near the tumor for treatment. HDR prostate brachytherapy is a similar internal treatment that involves the temporary placement of a tiny radioactive source directly into the tumor or near the targeted treatment area.

Civco’s EX3 Stepper, similar to its predecessor the EXII, provides compatibility for BK Medical, GE Healthcare, Hitachi Aloka, and Siemens transrectal ultrasound probes and it is currently validated for use with Varian Vitesse and VariSeed treatment-planning software.
In addition to receiving FDA 510(k) clearance, CIVCO has also CE Marked the EX3 for sale in the European Union and other countries where the CE Mark is recognized.

Related Links:

Civco Medical Solutions



RTI ELECTRONICS AB
SuperSonic Imagine
RADCAL

Channels

Radiography

view channel

Leading Cancer Center Among First in Europe to Treat Patients Using Robotic Patient-Positioning Radiotherapy Couch

A Viennese hospital has become one of the first oncology departments in Europe to introduce clinical treatments using a robotic radiotherapy patient-positioning couch. Kaiser-Franz-Josef Hospital (KFJ; Vienna, Austria) has introduced this enhanced patient positioning device, which enables more flexibility during radiotherapy... Read more

MRI

view channel
Image: The Accent MRI pacemaker and Tendril MRI lead (Photo courtesy of St. Jude Medical).

US Patent Allows Full-Body MRI Technology for Use with Pacemakers

A California hospital is first in the United States to conduct magnetic resonance imaging (MRI) of a patient implanted with a new MRI-compatible pacemaker. Cardiothoracic surgeon Raymond Schaerf, MD... Read more

Nuclear medicine

view channel
Image: Micrograph of Hodgkin lymphoma. Lymph node fine-needle aspiration (FNA) specimen. Field stain (Photo courtesy of Wikimedia Commons).

Early PET-Negative Stage I/II Hodgkin Lymphoma Patients Show Increased Risk of Early Relapse when Radiotherapy Is Not Used

Analysis of a new study indicates an increased risk of early relapse when excluding radiotherapy in early positron emission tomography (PET) scan-negative patients with stage I/II Hodgkin’s lymphoma.... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Imaging IT

view channel

Enterprise Image-Viewing System Receives FDA Clearance for Mobile Diagnosis on All Modalities

An enterprise image-viewing system is now cleared in the United States for diagnosis on mobile devices, for all imaging modalities (except mammography). Calgary Scientific, Inc. (Calgary, AB, USA) recently reported their latest Class II clearance from the US Food and Drug Administration (FDA). Calgary Scientific worked... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.